Global Journal of Respiratory Care https://savvysciencepublishers.com/index.php/gjrc <p>Global Journal of Respiratory Care is a peer-reviewed, open access journal that aims to cover the research and advancement in respiratory care and all relevant fields.</p> <p>We aim to serve all health care personnel dealing with respiratory care including pulmonologists, intensivists, anaesthesiologists, physicians, physiotherapists, critical care nurses and other allied healthcare professionals by publishing the high-quality scholarly content on recent developments in their fields.</p> <p>The Journal welcomes original research studies, review articles, case reports, clinical studies, meta-analysis, surveys and conference proceedings containing new insight into any aspect of respiratory care.</p> Savvy Science Publishers en-US Global Journal of Respiratory Care 2312-5470 A Case of Pleural Schwannoma Which Detected Incidental https://savvysciencepublishers.com/index.php/gjrc/article/view/890 <p>In addition to many devastating consequences of the covid 19 pandemic, which has affected all countries of the world, it has also caused reasons such as the diagnosis of most undiagnosed diseases. One of the most important reasons for this is the use of increasing imaging methods throughout the world during the pandemic. This result has enabled the incidental detection, early diagnosis and treatment of many lung pathologies other than the symptoms. Here, many pleural diseases progress with vague symptoms, and the patient's admission to the health institution is usually delayed. Pleural schwannomas are exceedingly rare neoplasms of the thoracic cavity. In the example of our case; pleural schwannoma, one of the rare pleural diseases detected incidentally, is discussed.</p> Mücahit Güleç Muhammed İnanç Ahmet Cemal Pazarlı Copyright (c) 2023 2023-02-23 2023-02-23 9 1 2 Effects of An Individualized Pulmonary Rehabilitation Program in Post-COVID Fibrosis: A Case Report https://savvysciencepublishers.com/index.php/gjrc/article/view/905 <p>Long COVID-19 Syndrome, in addition to symptoms such as chronic cough, exertional dyspnea and fatigue, pulmonary fibrosis is presented as specific respiratory system problems. Post-COVID fibrosis is characterized by radiographic abnormalities consistent with pulmonary fibrosis. Patients with post-COVID fibrosis may benefit from pulmonary rehabilitation programs. This case report aimed to investigate the effects of an individualized pulmonary rehabilitation (PR) program on selected clinical parameters in a 46-year-old male who was diagnosed with post-COVID fibrosis. Spirometry and diffusion tests were investigated. Six-minute walk and shuttle walk tests for exercise capacity, hand-held dynamometer for quadriceps muscle strength, mMrc dyspnea scale for dyspnea, Fatigue Severity Scale for fatigue and London Chest Activity of Daily Living for activities of daily living were evaluated. An individualized PR program included breathing exercises, single-leg cycle training (for the right leg, 10 to 30 min) and bilateral neuromuscular electrical stimulation for quadriceps muscles (30 min) was prescribed 3 days a week for 8 weeks. Small but promising improvements were observed in FEV1, FVC, FEV1/FVC, DLCO, 6MWD, shuttle walk tests walking distance and time, quadriceps muscle strength, mMRC and FSS scores. PR program combined with antifibrotic therapy has the potential to improve respiratory functions, exercise capacity, muscle strength, dyspnea, fatigue, and participation in ADL in patient with post-COVID fibrosis.</p> Ozge Ertan Harputlu Buket Akıncı Goksen Kuran Aslan Merve Sınem Oguz Gulfer Okumus Copyright (c) 2023 2023-05-02 2023-05-02 9 3 7 10.12974/2312-5470.2023.09.02 Respiratory Function, Physical Capacity, and Metabolic Syndrome Components in Combustible Cigarettes and Heated Tobacco Products Users: a Five-Year Follow-Up Cohort Study https://savvysciencepublishers.com/index.php/gjrc/article/view/991 <p><strong><em>P</em></strong><strong><em>urpose: </em></strong>Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide and is the fourth leading cause of death in Kazakhstan. Cigarette smoking is a prevalent risk factor for COPD. While quitting smoking is the preferred way to reduce COPD risk, literature suggests that heated tobacco products (HTP) might be a better option for people who cannot quit smoking. The aim of this paper was to analyze the long-term effects of shifting to HTP use in long- term smokers compared to continued combustible cigarettes (CC) use. <strong><em>P</em></strong><strong><em>atients and methods: </em></strong>A cohort of 1200 participants (393 HTP and 807 CC) aged 40-59 years with a minimum of 10 pack-year smoking history were recruited and followed for five years. The functional outcomes compared between HTP, CC users and No-Smokers (NS, people who stopping smoking) included: (1) COPD Assessment Test (CAT); (2) post-bronchodilator lung function; (3) 6-minute walking distance (6MWD) test; and (4) metabolic syndrome components. Multivariable linear mixed models (MIXED) were used to compare functional outcomes between visits and to test associations between health outcomes and smoking type (HTP vs. CC vs. NS) over time. <strong><em>Results: </em></strong>Out of 1200 participants 830 (466 CC users, 248 HTP users and 116 No-Smokers) remained in the study by the fifth year of follow up. Linear mixed models showed HTP use was associated with better CAT scores and HDL cholesterol level compared to CC users. Lung function (FVC) decrease was significantly less in HTP users. FEV, 6MWD, waist circumference, fasting blood glucose, triglycerides and diastolic blood pressure significantly changes over time, but without between-group difference in dynamic. <strong><em>Conclusion: </em></strong>This study demonstrated that HTP users experienced it to a significantly lesser decrease in lung function by FVC compared to CC users over time (in time dependent model), while demonstrating better stable levels in other functional outcomes. The results of this study suggest that HTP might be a less deleterious alternative compared to CC in people with long history of CC use and who cannot quit smoking.</p> Almaz Sharman Vladimir Arnautov Irina Yermakova Gulnara Tyulebekova Aisulu Bekzhanova Elmira Erenchina Sattar Yeraliyev Copyright (c) 2024 2023-12-31 2023-12-31 9 8 24 10.12974/2312-5470.2023.09.03